花粉萃取物對慢性攝護腺炎慢性骨盆腔疼痛症候群患者的療效 ... | 合法藥品大搜索

2020年5月29日—之後隨機分為兩組，分別接受花粉萃取物(每8小時口服2顆膠囊，每顆膠囊內含活性物質：60毫克的CernitinT60與3毫克的CernitinGBX)或是安慰 ...

Background: National Institutes of Health (NIH) category III prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent condition for which no standardised treatment exists. Objectives: To assess the safety and efficacy of a standardised pollen extract in men with inflammatory CP/CPPS.

Design, setting, and participants: We conducted a multicentre, prospective, randomised, double-blind, placebo-controlled phase 3 study comparing the pollen extract (Cernilton) to placebo in men with CP/CPPS (NIH IIIA) attending urologic centres. Intervention: Participants were randomised to receive oral capsules of the pollen extract (two capsules q8 h) or placebo for 12 wk.

Measurements: The primary endpoint of the study was symptomatic improvement in the pain domain of the NIH Chronic Prostatitis Symptom Index (NIH-CPSI). Participants were evaluated using the NIH-CPSI individual domains and total score, the number of l...